Apigenin enhances viability of random skin flaps by activating autophagy

Phytother Res. 2021 Jul;35(7):3848-3860. doi: 10.1002/ptr.7090. Epub 2021 Apr 1.

Abstract

Random skin flap is widely used in plastic surgery. However, flap necrosis caused by ischemia-reperfusion injury limits its clinical applications. Apigenin, a naturally occurring flavonoid mainly derived from plants, facilitates flap survival. In this study, we explored the effects of apigenin on flap survival and the underlying mechanisms. A total of 54 mice having a dorsal random flap model were randomly divided into control, apigenin, and apigenin +3-methyladenine groups. These groups were treated with dimethyl sulfoxide solution, apigenin, and apigenin +3-methyladenine, respectively. The animals were then euthanized to assess angiogenesis, apoptosis, oxidative stress, and autophagy levels through histological and protein analyses. Apigenin promotes survival of the skin flap area and reduces tissue edema. In addition, apigenin enhanced angiogenesis, attenuated apoptosis, alleviated oxidative stress, and activated autophagy. Interestingly, 3-methyladenine reversed the effects of apigenin on flap survival, angiogenesis, apoptosis, and oxidative stress through inhibition of autophagy. The findings of this study show that apigenin promotes angiogenesis, inhibits cell apoptosis, and lowers oxidative stress by mediating autophagy, thus the improving survival rate of random skin flaps.

Keywords: angiogenesis; apigenin; apoptosis; autophagy; oxidative stress; random skin flaps.

MeSH terms

  • Angiogenesis Inducing Agents
  • Animals
  • Apigenin* / pharmacology
  • Apoptosis / drug effects
  • Autophagy*
  • Graft Survival / drug effects*
  • Mice
  • Oxidative Stress
  • Skin* / metabolism
  • Surgical Flaps*

Substances

  • Angiogenesis Inducing Agents
  • Apigenin